Effectiveness of posthemodialysis administration of pregabalin (75 mg) in treatment resistance uremia pruritus

• Published in: Journal of pharmacy & bioallied science Vol. 8; no. 1; pp. 74 - 76
• Main Authors: Khan, Tahir, Aziz, Abdul, Suleiman, Amal
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer - Medknow Publications 01-01-2016; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd; Medknow Publications & Media Pvt Ltd; Wolters Kluwer Medknow Publications
• Subjects: Dosage and administration; Drug therapy; Patient outcomes; Pregabalin; renal failure; Short Communication; Uremia; uremic pruritus; renal failure; uremic pruritus; Pregabalin
• ISSN: 0975-7406; 0976-4879; 0975-7406; 0976-4879
• DOI: 10.4103/0975-7406.171736

Uremic pruritus (UP) is one of the complications faced by majority of the patients with end stage renal disease (ESRD). Due to complex pathophysiology of UP, most of the anti-inflammatory and tropical lubricants often not provide a long lasting control over pruritus. Recently the uses of certain anti-epileptics are found to demonstrate promising relief to UP. To test the effect of 75 mg pregabalin in patients with treatment resistance pruritus. Data was prospectively collected from a patient with ESRD and suffering from treatment resistance pruritus. Intensity of pruritus was recorded using 5D-itching scale (5D-IS) and visual analogue scale (VAS). Pre and post assessment was done for this patient, on initial assess the parathyroid hormone level of the patient was 70.5 pg/ml with a serum phosphate level of 2.61 mmol/L. Upon initial assess the VAS score was 8 and 5D-IS score was twenty. After the duration of four weeks of pregabalin 75 mg post hemodialysis, 5D-IS score reduced to 8 and VAS score move down to 3. Pregabalin 75 mg post hemodialysis was found to reduce the intensity of UP. Pregabalin 75 mg post hemodialysis can be another option to treat UP.